UPBD:NASDAQUpbound Group, Inc. Analysis
Data as of 2026-05-07 - not real-time
$18.76
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Upbound Group (UPBD) trades at a trailing PE of 13x, well below the software industry average of 37x, while its forward PE plunges to under 4x, indicating significant earnings upside. The stock yields an 8.2% dividend but the payout ratio exceeds 100%, raising sustainability concerns despite robust free cash flow of $1.56 B. With a market price of $18.76, analysts project a median target of $28, implying roughly 50% upside, and the consensus recommendation is a strong buy amid an “Extreme Greed” market sentiment.
Technical indicators show the price below the 20‑day SMA and a bearish MACD histogram, suggesting short‑term pressure, yet the stock sits near a support level of $17.93 and volume is increasing. High beta (≈1.9) and 30‑day volatility near 39% flag elevated market risk, compounded by a debt‑to‑equity ratio over 240%, while the company’s modest 3.7% revenue growth and solid operating cash flow provide a defensive cushion for medium‑ to long‑term investors.
Technical indicators show the price below the 20‑day SMA and a bearish MACD histogram, suggesting short‑term pressure, yet the stock sits near a support level of $17.93 and volume is increasing. High beta (≈1.9) and 30‑day volatility near 39% flag elevated market risk, compounded by a debt‑to‑equity ratio over 240%, while the company’s modest 3.7% revenue growth and solid operating cash flow provide a defensive cushion for medium‑ to long‑term investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near technical support at $17.93
- Upcoming Q1 earnings release
- High dividend yield but sustainability concerns
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap vs industry peers
- Strong free cash flow supporting growth
- Analyst consensus target of $28 and strong‑buy rating
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Potential for earnings acceleration reflected in forward PE
- Strategic positioning in underserved consumer finance market
- Elevated leverage and dividend payout risk requiring monitoring
Key Metrics & Analysis
Financial Health
Revenue Growth3.70%
Profit Margin1.78%
P/E Ratio13.0
ROE12.08%
ROA7.36%
Debt/Equity241.44
P/B Ratio1.6
Op. Cash Flow$328.2M
Free Cash Flow$1.6B
Industry P/E37.2
Technical Analysis
TrendNeutral
RSI47.5
Support$17.93
Resistance$20.99
MA 20$19.20
MA 50$18.93
MA 200$20.58
MACDBearish
VolumeIncreasing
Fear & Greed Index90.93
Valuation
Fair Value$393.00
Target Price$28.50
Upside/Downside51.92%
GradeUndervalued
TypeBlend
Dividend Yield8.21%
Risk Assessment
Beta1.88
Volatility38.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.